Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), bought 5,000 shares at $1.98 ($10K) on 2014-08-11, disclosed to the SEC on 2014-08-13.
Open-market purchase of $10k ATRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |